{"id":"https://openalex.org/W4366238465","doi":"https://doi.org/10.1007/s00296-023-05329-y","title":"Ixekizumab for brodalumab-induced articular involvement in psoriatic arthritis: beyond IL-17A inhibition","display_name":"Ixekizumab for brodalumab-induced articular involvement in psoriatic arthritis: beyond IL-17A inhibition","publication_year":2023,"publication_date":"2023-04-18","ids":{"openalex":"https://openalex.org/W4366238465","doi":"https://doi.org/10.1007/s00296-023-05329-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/37071177"},"language":"en","primary_location":{"id":"doi:10.1007/s00296-023-05329-y","doi":"https://doi.org/10.1007/s00296-023-05329-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00296-023-05329-y","pdf_url":null,"source":{"id":"https://openalex.org/S50823678","display_name":"Rheumatology International","issn_l":"0172-8172","issn":["0172-8172","1437-160X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology International","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038371392","display_name":"Tomoyuki Mutoh","orcid":"https://orcid.org/0000-0001-5995-8609","observed_orcids":["https://orcid.org/0000-0001-5995-8609"]},"institutions":[{"id":"https://openalex.org/I4210110954","display_name":"Osaki Citizen Hospital","ror":"https://ror.org/01paha414","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210110954"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tomoyuki Mutoh","raw_affiliation_strings":["Department of Rheumatology, Osaki Citizen Hospital, 3-8-1 Furukawa Honami, Osaki, Miyagi, 989-6183, Japan. qma-kyo@hotmail.co.jp","Department of Rheumatology, Osaki Citizen Hospital, 3-8-1 Furukawa Honami, Osaki, Miyagi, 989-6183, Japan"],"raw_orcid":"https://orcid.org/0000-0001-5995-8609","affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Osaki Citizen Hospital, 3-8-1 Furukawa Honami, Osaki, Miyagi, 989-6183, Japan. qma-kyo@hotmail.co.jp","institution_ids":["https://openalex.org/I4210110954"]},{"raw_affiliation_string":"Department of Rheumatology, Osaki Citizen Hospital, 3-8-1 Furukawa Honami, Osaki, Miyagi, 989-6183, Japan","institution_ids":["https://openalex.org/I4210110954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013252958","display_name":"Masataka Kudo","orcid":"https://orcid.org/0000-0001-5916-1202","observed_orcids":["https://orcid.org/0000-0001-5916-1202"]},"institutions":[{"id":"https://openalex.org/I4210110954","display_name":"Osaki Citizen Hospital","ror":"https://ror.org/01paha414","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210110954"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masataka Kudo","raw_affiliation_strings":["Department of Nephrology and Endocrinology, Osaki Citizen Hospital, Osaki, Miyagi, Japan","Department of Rheumatology, Osaki Citizen Hospital, 3-8-1 Furukawa Honami, Osaki, Miyagi, 989-6183, Japan"],"raw_orcid":"https://orcid.org/0000-0001-5916-1202","affiliations":[{"raw_affiliation_string":"Department of Nephrology and Endocrinology, Osaki Citizen Hospital, Osaki, Miyagi, Japan","institution_ids":["https://openalex.org/I4210110954"]},{"raw_affiliation_string":"Department of Rheumatology, Osaki Citizen Hospital, 3-8-1 Furukawa Honami, Osaki, Miyagi, 989-6183, Japan","institution_ids":["https://openalex.org/I4210110954"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002482263","display_name":"Akira Tsukada","orcid":"https://orcid.org/0009-0009-5507-2865","observed_orcids":["https://orcid.org/0009-0009-5507-2865"]},"institutions":[{"id":"https://openalex.org/I4210110954","display_name":"Osaki Citizen Hospital","ror":"https://ror.org/01paha414","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210110954"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akira Tsukada","raw_affiliation_strings":["Department of Dermatology, Osaki Citizen Hospital, Osaki, Miyagi, Japan"],"raw_orcid":"https://orcid.org/0009-0009-5507-2865","affiliations":[{"raw_affiliation_string":"Department of Dermatology, Osaki Citizen Hospital, Osaki, Miyagi, Japan","institution_ids":["https://openalex.org/I4210110954"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5038371392"],"corresponding_institution_ids":["https://openalex.org/I4210110954"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.3417,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.53883783,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"43","issue":"8","first_page":"1559","last_page":"1561"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.08169999718666077,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.9639999866485596},{"id":"https://openalex.org/keywords/il-17a-inhibition","display_name":"IL-17A inhibition","score":0.8500000238418579},{"id":"https://openalex.org/keywords/il-23-inhibition","display_name":"IL-23 inhibition","score":0.7039999961853027},{"id":"https://openalex.org/keywords/joint-involvement","display_name":"joint involvement","score":0.6880000233650208},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6309999823570251},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C2779745271","wikidata":"https://www.wikidata.org/wiki/Q13574436","display_name":"Ixekizumab","level":5,"score":0.9747188091278076},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9394630193710327},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.8162351846694946},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.6711201667785645},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4517119526863098},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.4471995234489441},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4441331624984741},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.36671268939971924},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3528245687484741}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020381","descriptor_name":"Interleukin-17","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00296-023-05329-y","doi":"https://doi.org/10.1007/s00296-023-05329-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00296-023-05329-y","pdf_url":null,"source":{"id":"https://openalex.org/S50823678","display_name":"Rheumatology International","issn_l":"0172-8172","issn":["0172-8172","1437-160X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology International","raw_type":"journal-article"},{"id":"pmid:37071177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37071177","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology international","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6839767668","display_name":"Identification of pathogenesis of novel autoantibodies in Takayasu arteritis","funder_award_id":"20K17419","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W2551467523","https://openalex.org/W2619281205","https://openalex.org/W2797551684","https://openalex.org/W3089057696","https://openalex.org/W4220809827","https://openalex.org/W4225405114","https://openalex.org/W4228997515","https://openalex.org/W4321996905"],"related_works":["https://openalex.org/W2625170996","https://openalex.org/W2792437346","https://openalex.org/W2113034544","https://openalex.org/W3002931386","https://openalex.org/W3164689273","https://openalex.org/W2912970116","https://openalex.org/W3175887397","https://openalex.org/W3094072094","https://openalex.org/W4410861066","https://openalex.org/W4231962459"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-20T00:00:00"}